These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11251637

  • 21. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
    Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y.
    Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
    Matsumoto T, Wada A, Tsutamoto T, Omura T, Yokohama H, Ohnishi M, Nakae I, Takahashi M, Kinoshita M.
    Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
    [Abstract] [Full Text] [Related]

  • 25. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity.
    Henry PJ, Horowitz JD, Louis WJ.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of vasodilation by nitrates: role of cyclic GMP.
    Kukovetz WR, Holzmann S, Romanin C.
    Cardiology; 1987 Mar; 74 Suppl 1():12-9. PubMed ID: 2886220
    [Abstract] [Full Text] [Related]

  • 27. Vasorelaxing effects of the soluble guanylyl cyclase activator BAY 60-2770 in nitrate-tolerant monkey and canine coronary arteries.
    Tawa M, Shimosato T, Iwasaki H, Imamura T, Okamura T.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):381-5. PubMed ID: 25582420
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.
    He GW, Yang CQ.
    Br J Clin Pharmacol; 1999 Jul; 48(1):99-104. PubMed ID: 10383566
    [Abstract] [Full Text] [Related]

  • 29. Increased nitric oxide concentrations in posterior hypothalamus and central sympathetic function on nitrate tolerance following subcutaneous nitroglycerin.
    Ma SX, Ignarro LJ, Byrns R, Li XY.
    Nitric Oxide; 1999 Jul; 3(2):153-61. PubMed ID: 10369185
    [Abstract] [Full Text] [Related]

  • 30. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance.
    Watanabe H, Kakihana M, Ohtsuka S, Enomoto T, Yasui K, Sugishita Y.
    Circulation; 1993 Jul; 88(1):29-36. PubMed ID: 8391401
    [Abstract] [Full Text] [Related]

  • 31. Co-operation between particulate and soluble guanylyl cyclase systems in the rat renal glomeruli.
    Stepinski J, Wendt U, Lewko B, Angielski S.
    J Physiol Pharmacol; 2000 Sep; 51(3):497-511. PubMed ID: 11016869
    [Abstract] [Full Text] [Related]

  • 32. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
    Kuromaru O, Sakai K.
    Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
    Merkel LA, Rivera LM, Perrone MH, Lappe RW.
    Eur J Pharmacol; 1992 May 27; 216(1):29-35. PubMed ID: 1326438
    [Abstract] [Full Text] [Related]

  • 34. Studies of vascular tolerance to nitroglycerin: effects of N-acetylcysteine, NG-monomethyl L-arginine, and endothelin-1.
    Lawson DL, Haught WH, Mehta P, Mehta JL.
    J Cardiovasc Pharmacol; 1996 Sep 27; 28(3):418-24. PubMed ID: 8877589
    [Abstract] [Full Text] [Related]

  • 35. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.
    Saijonmaa O, Ristimäki A, Fyhrquist F.
    Biochem Biophys Res Commun; 1990 Dec 14; 173(2):514-20. PubMed ID: 2175599
    [Abstract] [Full Text] [Related]

  • 36. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
    Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG.
    J Clin Invest; 1995 Jan 14; 95(1):187-94. PubMed ID: 7814613
    [Abstract] [Full Text] [Related]

  • 37. Effects of glutathione S-transferase inhibitors on nitroglycerin action in pig isolated coronary arteries.
    Matsuzaki T, Sakanashi M, Nakasone J, Noguchi K, Miyagi K, Sakanashi M, Kukita I, Aniya Y, Sakanashi M.
    Clin Exp Pharmacol Physiol; 2002 Dec 14; 29(12):1091-5. PubMed ID: 12390297
    [Abstract] [Full Text] [Related]

  • 38. Effects of nitric oxide and noradrenergic activation in the posterior hypothalamus on arterial pressure tolerance to nitroglycerin in rats.
    Guettler DL, Ma SX.
    J Cardiovasc Pharmacol Ther; 2008 Jun 14; 13(2):98-106. PubMed ID: 18375750
    [Abstract] [Full Text] [Related]

  • 39. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion.
    Sage PR, de la Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, Horowitz JD.
    Circulation; 2000 Dec 05; 102(23):2810-5. PubMed ID: 11104737
    [Abstract] [Full Text] [Related]

  • 40. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y, Takemura S, Hai S, Suehiro S, Okada S.
    Free Radic Biol Med; 2006 Mar 01; 40(5):808-16. PubMed ID: 16520233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.